Peng Yan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Extracorporeal Membrane Oxygenation

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Lung Cancer (Auckland, N.Z.)

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Xue-Jun Dou, Run-Yang Ma, De-Wang Ren, Qiang Liu, Peng Yan
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study. Lung Cancer (Auckland, N.Z.) 15 (2024)
Xue-Jun Dou, Run-Yang Ma, De-Wang Ren, Qiang Liu, Peng Yan
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study. Lung Cancer (Auckland, N.Z.) 15 (2024)
Kun Xiao, Lei Song, Ye Hu, Wanxue He, Fei Hou, Peng Yan, Jianqiao Xu, Kaifei Wang, Yi Tao, Dan Li, Lixin Xie
Novel Role of miR-18a-5p and Galanin in Rat Lung Ischemia Reperfusion-Mediated Response. Oxidative medicine and cellular longevity 2021 (2021)